Charles River Laboratories has entered a definitive agreement to acquire WIL Research for approximately $585 million in cash, subject to customary closing conditions.   WIL Research provides safety assessment and contract development and manufacturing services to biopharmaceutical, agricultural, and industrial chemical companies globally. The acquisition expands Charles River’s early-stage contract research services with access to global clients across drug discovery and development.   James...